Wonder if PAOgroup will bail RBII out of the grey market thru reverse merger if that's where they are relegated. Couldn't hurt, rt? As long as the Oxi-Thyme tm spray bottles got the EPA CDC FDA stamp of approval. Wonder if that would cause SEC to scrutinize PAOgroup's pink current success as well. I don't think the sister company would just let her sister co. Or former sister or whoever just Flail and dye on the grey market. But then again nobody knows for sure what the final outcome of these companies or products and their respective markets will be. I feel like a reverse merger in which RBII and PAOgroup become 1 mega company w multiple ventures, products pieline and revenue streams w NIH interest and contracts across U.S. would be best for potential value. Just an idea.
News 
Market Data 
Discover 
AI
